NCT03072823View on ClinicalTrials.gov

Omega-3 Polyunsaturated Fatty Acids on Major Depressive Disorder in Patients With Cardiovascular Diseases

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 27, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

June 30, 2017

Conditions
Cardiovascular DiseasesMajor Depressive Disorder
Interventions
DIETARY_SUPPLEMENT

n-3 Polyunsaturated fatty acid

2 g of Eicosapentaenoic acid (EPA) and 1 g of Docosahexaenoic acid (DHA)

DIETARY_SUPPLEMENT

placebo

olive oil ethyl esters

Trial Locations (1)

404

China Medical University, Taichung

All Listed Sponsors
collaborator

National Science and Technology Council, Taiwan

OTHER_GOV

lead

China Medical University Hospital

OTHER

NCT03072823 - Omega-3 Polyunsaturated Fatty Acids on Major Depressive Disorder in Patients With Cardiovascular Diseases | Biotech Hunter | Biotech Hunter